The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Display technologies: Application for the discovery of drug and gene delivery agents☆
Open accessAbstract
Recognition of molecular diversity of cell surface proteomes in disease is essential for the development of targeted therapies. Progress in targeted therapeutics requires establishing effective approaches for high-throughput identification of agents specific for clinically relevant cell surface markers. Over the past decade, a number of platform strategies have been developed to screen polypeptide libraries for ligands targeting receptors selectively expressed in the context of various cell surface proteomes. Streamlined procedures for identification of ligand-receptor pairs that could serve as targets in disease diagnosis, profiling, imaging and therapy have relied on the display technologies, in which polypeptides with desired binding profiles can be serially selected, in a process called biopanning, based on their physical linkage with the encoding nucleic acid. These technologies include virus/phage display, cell display, ribosomal display, mRNA display and covalent DNA display (CDT), with phage display being by far the most utilized. The scope of this review is the recent advancements in the display technologies with a particular emphasis on molecular mapping of cell surface proteomes with peptide phage display. Prospective applications of targeted compounds derived from display libraries in the discovery of targeted drugs and gene therapy vectors are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
Peptide Phage Display: Opportunities for Development of Personalized Anti-Cancer Strategies
Samoylova, T. I., Morrison, N. E., Globa, L. P., & Cox, N. R. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006774755492 · Cited by 48
Jose, J., Betscheider, D., & Zangen, D. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.08.019 · Cited by 48
Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma
Ozawa, M. G., Yao, V. J., Chanthery, Y. H., Troncoso, P., Uemura, A., Varner, A. S., Kasman, I. M., Pasqualini, R., Arap, W., & McDonald, D. M. (2005) · Cancer · doi:10.1002/cncr.21436 · Cited by 48
Self-citationShukla, G. S., & Krag, D. N. (2005) · Journal of drug targeting · doi:10.1080/10611860400020464 · Cited by 48
NCI's anticancer drug screening program may not be selecting for clinically active compounds.
Brown, J. M. (1997) · PubMed · Cited by 46
Monoclonal and recombinant antibodies, 30 years after …
Laffly, E., & Sodoyer, R. (2006) · Human Antibodies · doi:10.3233/hab-2005-141-206 · Cited by 46
Bacterial Phage Receptors, Versatile Tools for Display of Polypeptides on the Cell Surface
Etz, H., Minh, D. B., Schellack, C., Nagy, E., & Meinke, A. L. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6924-6935.2001 · Cited by 46
Antiphospholipid antibodies may be a new prognostic parameter in aggressive non‐Hodgkin's lymphoma
Bairey, O., Blickstein, D., Monselise, Y., Lahav, J., Stark, P., Prokocimer, M., Magen‐Nativ, H., Kirgner, I., Pazgal, I., & Shaklai, M. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00620.x · Cited by 44
Teratogenicity induced by targeting a placental immunoglobulin transporter
Kolonin, M. G., Pasqualini, R., & Arap, W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468499 · Cited by 44
Self-citationRibosome display for improved biotherapeutic molecules
Rothe, A., Hosse, R. J., & Power, B. E. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.2.177 · Cited by 44
Gene profiling techniques and their application in angiogenesis and vascular development
Peale, F. V., Jr., & Gerritsen, M. E. (2001) · The Journal of Pathology · doi:10.1002/path.888 · Cited by 42
Modulation of the immune response by systemic targeting of antigens to lymph nodes.
Trepel, M., Arap, W., & Pasqualini, R. (2001) · PubMed · Cited by 42
Self-citationDrăghici, S., Chatterjee, M., & Tainsky, M. A. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.5.735 · Cited by 41
Gao, C., Mao, S., Ronca, F., Zhuang, S., Quaranta, V., Wirsching, P., & Janda, K. D. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00522-7 · Cited by 41
Recombinant polyclonal antibodies for cancer therapy
Sharon, J., Liebman, M. A., & Williams, B. R. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20536 · Cited by 40
Bachelot, T., Ratel, D., Ménétrier‐Caux, C., Wion, D., Blay, J., & Berger, F. R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603037 · Cited by 39
Yazıcı, S., Kim, S. J., Busby, J. E., He, J., Thaker, P. H., Yokoi, K., Fan, D., & Fidler, I. J. (2005) · The Prostate · doi:10.1002/pros.20283 · Cited by 37
Eichler, J. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053258497 · Cited by 37
Denkberg, G., & Reiter, Y. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.07.004 · Cited by 36
Tarnovitski, N., Matthews, L. J., Sui, J., Gershoni, J. M., & Marasco, W. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.008 · Cited by 33
Wallqvist, A., Rabow, A. A., Shoemaker, R. H., Sausville, E. A., & Covell, D. G. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg302 · Cited by 32
General Strategy for Broadening Adenovirus Tropism
Fontana, L., Nuzzo, M., Urbanelli, L., & Monaci, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11094-11104.2003 · Cited by 32
Hill, H. R., & Stockley, P. G. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02508.x · Cited by 31
Immunotherapeutic peptide vaccination with leukemia-associated antigens
Rusakiewicz, S., & Molldrem, J. J. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.07.005 · Cited by 30
Self-citationRevisiting Ethical Guidelines for Research with Terminal Wean and Brain-Dead Participants
Pentz, R. D., Flamm, A. L., Pasqualini, R., Logothetis, C. J., & Arap, W. (2003) · The Hastings Center Report · doi:10.2307/3527910 · Cited by 30
Self-citationAntiangiogenic Therapy Decreases Integrin Expression in Normalized Tumor Blood Vessels
Yao, V. J., Ozawa, M. G., Varner, A. S., Kasman, I. M., Chanthery, Y. H., Pasqualini, R., Arap, W., & McDonald, D. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1824 · Cited by 29
Self-citationPini, A., Runci, Y., Falciani, C., Lelli, B., Brunetti, J., Pileri, S., Fabbrini, M., Lozzi, L., Ricci, C., Bernini, A., et al. (2006) · Biochemical Journal · doi:10.1042/bj20051747 · Cited by 28
Scooby-domain: prediction of globular domains in protein sequence
George, R. A., Lin, K., & Heringa, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki381 · Cited by 28
Hunting Interactomes of a Membrane Protein
Roman, I., Figys, J., Steurs, G., & Zizi, M. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600009-mcp200 · Cited by 28
Boulter, J. M., & Jakobsen, B. K. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02929.x · Cited by 27
Protein-protein interactions in hematology and phage display
Mullaney, B. P., & Pallavicini, M. G. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00693-2 · Cited by 25
Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme
Paradis‐Bleau, C., Beaumont, M., Boudreault, L., Lloyd, A. J., Sanschagrin, F., Bugg, T. D. H., & Lévesque, R. C. (2006) · Peptides · doi:10.1016/j.peptides.2006.01.017 · Cited by 24
Phage display as a novel screening method to identify extracellular proteins
Rosander, A., Bjerketorp, J., Frykberg, L., & Jacobsson, K. (2002) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(02)00052-0 · Cited by 23
Phage display of peptide/major histocompatibility complex
Doussal, J. L., Piqueras, B., Dogan, I., Debré, P., & Gorochov, G. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00211-8 · Cited by 20
Phage‐Displayed Antibodies for the Detection of Glycated Proteasome in Aging Cells
Gonzalez‐Dosal, R., Sørensen, M. D., Clark, B. F. C., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.068 · Cited by 18
THE USE OF PHAGE DISPLAY IN THE STUDY OF RECEPTORS AND THEIR LIGANDS
Hartley, O. (2002) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-120014608 · Cited by 18
Hitoshi, Y., Gururaja, T. L., Pearsall, D., Lang, W., Sharma, P., Huang, B. C. B., Catalano, S. M., McLaughlin, J. R., Pali, E. S., Peelle, B. R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.009 · Cited by 16
A phage display system for detection of T cell receptor-antigen interactions
Onda, T., LaFace, D., Baier, G., Brunner, T., Honma, N., Mikayama, T., Altman, A., & Green, D. R. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00098-4 · Cited by 12
Development and virtual screening of target libraries
Rognan, D. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.084 · Cited by 11
pH-Dependent Lytic Peptides Discovered by Phage Display
Hirosue, S., & Weber, T. (2006) · Biochemistry · doi:10.1021/bi052488s · Cited by 11
Rudert, F., Woltering, C., Frisch, C., Rottenberger, C., & Ilag, L. L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01413-6 · Cited by 11
A Human Neutralizing Antibody against a Conformational Epitope Shared by Oligomeric Sars S1 Protein
Duan, J., Ji, X., Feng, J., Han, W., Zhang, P., Cao, W., Guo, X., Cai, Q., Yang, D., Jin, G., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100101 · Cited by 10
Lu, S., Wieder, E., Komanduri, K. V., Ma, Q., & Molldrem, J. J. (2004) · Advances in pharmacology · doi:10.1016/s1054-3589(04)51011-6 · Cited by 6
Self-citation
Cited by
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Self-citationStimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., Bungau, S., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 581
Phage display and other peptide display technologies
Jaroszewicz, W., Morcinek-Orłowska, J., Pierzynowska, K., Gaffke, L., & Węgrzyn, G. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab052 · Cited by 331
Metadata
- Authors
- SERGEEVA, A., KOLONIN, M., MOLLDREM, J., PASQUALINI, R., & ARAP, W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2006-12-30
- Volume
- 58
- Issue
- 15
- Pages
- 1622-1654
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2060742905
- Cited by
- 266
- References
- 243
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.